Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ADPT

Stock Name	Adaptive Biotechnologies Corp
Ticker	ADPT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US00650F1093
LEI	549300ZTF7OT1FW66Q96

Show aggregate ADPT holdings

News associated with ADPT

ADPT Crosses Above Average Analyst Target: In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $13.25, changing hands for $13.49/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow - 2025-09-12 08:06:46
Analysts Set Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Price Target at $12.38: Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective […] - 2025-09-10 02:16:59
Adaptive Biotechnologies Reaches Analyst Target Price: In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $12.12, changing hands for $12.54/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow - 2025-08-08 08:23:12
Adaptive Biotechnologies (NASDAQ:ADPT) Given New $15.00 Price Target at TD Cowen: Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price target upped by stock analysts at TD Cowen from $13.00 to $15.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price would suggest a potential upside of 19.62% from the […] - 2025-08-08 03:02:57
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High Following Strong Earnings: Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report. The company traded as high as $12.83 and last traded at $10.93, with a volume of 742398 shares traded. The stock had previously closed at $11.05. The company […] - 2025-08-08 02:19:02
Victory Capital Management Inc. Grows Stock Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT): Victory Capital Management Inc. boosted its stake in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Free Report) by 9,892.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,764,227 shares of the company’s stock after buying an additional 1,746,571 shares during the period. Victory Capital Management Inc.’s […] - 2025-07-24 04:53:21
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives $10.57 Consensus PT from Brokerages: Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month target […] - 2025-07-22 02:10:47
D.A. Davidson & CO. Has $682,000 Stock Holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT): D.A. Davidson & CO. boosted its holdings in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Free Report) by 3.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 91,850 shares of the company’s stock after acquiring an additional 3,400 shares during the period. D.A. Davidson & CO.’s holdings […] - 2025-07-10 05:25:16
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives $10.57 Average Target Price from Brokerages: Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target […] - 2025-06-27 02:10:57
Adaptive Biotechnologies Reaches Analyst Target Price: In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $11.62, changing hands for $11.98/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow - 2025-06-26 08:37:35
Adaptive Biotechnologies (NASDAQ:ADPT) Coverage Initiated at Craig Hallum: Equities research analysts at Craig Hallum assumed coverage on shares of Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 43.27% from […] - 2025-06-20 02:15:14
Brighton Jones LLC Has $166,000 Stock Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT): Brighton Jones LLC decreased its position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Free Report) by 8.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,318 shares of the company’s stock after selling 1,971 shares during the period. Brighton Jones […] - 2025-06-19 05:35:04
Rhumbline Advisers Acquires 7,322 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT): Rhumbline Advisers raised its holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Free Report) by 4.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 188,524 shares of the company’s stock after buying an additional 7,322 shares during the quarter. Rhumbline Advisers’ holdings in Adaptive […] - 2025-06-19 04:42:43
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 118,593 shares of the company’s stock, valued at approximately $711,000. A number of other institutional investors also recently bought […] - 2025-06-11 04:38:55
Analysts Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Target Price at $9.83: Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have received a consensus rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year […] - 2025-06-02 02:50:50
Quantinno Capital Management LP Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT): Quantinno Capital Management LP acquired a new stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 16,688 shares of the company’s stock, valued at approximately $100,000. A number of other […] - 2025-05-29 04:59:02
Deutsche Bank AG Grows Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT): Deutsche Bank AG boosted its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 397.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 630,577 shares of the company’s stock after buying an additional 503,842 shares during the period. Deutsche Bank AG owned approximately […] - 2025-05-20 05:14:56
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Strong Trading Volume Following Analyst Upgrade: Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) saw unusually-strong trading volume on Monday after Morgan Stanley raised their price target on the stock from $7.00 to $9.00. Morgan Stanley currently has an equal weight rating on the stock. Approximately 1,380,969 shares traded hands during mid-day trading, a decline of 11% from the […] - 2025-05-07 02:21:01
Adaptive Biotechnologies Reaches Analyst Target Price: In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $9.86, changing hands for $10.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down - 2025-05-06 08:20:53
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Expected to Rise, Morgan Stanley Analyst Says: Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price target lifted by Morgan Stanley from $7.00 to $9.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock. Other analysts have also recently issued research reports about the stock. Scotiabank raised their price objective on […] - 2025-05-06 02:55:06
Analysts Predict 30% Upside For DWAS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-02 08:52:50
Guggenheim Capital LLC Cuts Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT): Guggenheim Capital LLC trimmed its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 19.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,845 shares of the company’s stock after selling 10,093 shares during the quarter. Guggenheim Capital LLC’s […] - 2025-04-29 05:30:55
Prudential Financial Inc. Boosts Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT): Prudential Financial Inc. grew its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 3,290.8% during the 4th quarter, HoldingsChannel reports. The fund owned 481,965 shares of the company’s stock after purchasing an additional 467,751 shares during the period. Prudential Financial Inc.’s holdings in Adaptive Biotechnologies were worth $2,889,000 at the end of the […] - 2025-04-03 05:16:55
Is Bio-Techne Corporation Stock Underperforming the S&P 500?: Despite Bio-Techne Corporation’s underperformance relative to the S&P 500 over the past year, analysts maintain a bullish outlook on the stock’s prospects. - 2025-04-01 10:41:17
Analysts Anticipate 27% Upside For The Holdings of VB: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-01 08:04:16
Intech Investment Management LLC Purchases 11,865 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT): Intech Investment Management LLC increased its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 34.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 46,158 shares of the company’s stock after buying an additional 11,865 shares during the period. Intech Investment Management LLC’s holdings in Adaptive Biotechnologies were worth $277,000 as of its […] - 2025-03-27 06:22:57
Adaptive Biotechnologies (NASDAQ:ADPT) Upgraded at The Goldman Sachs Group: The Goldman Sachs Group upgraded shares of Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) from a neutral rating to a buy rating in a research report released on Friday, Marketbeat.com reports. The Goldman Sachs Group currently has $9.00 price objective on the stock, up from their previous price objective of $8.00. ADPT has been the topic […] - 2025-03-24 04:28:56
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 6.1% on Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s stock price fell 6.1% on Thursday after an insider sold shares in the company. The company traded as low as $7.46 and last traded at $7.15. 41,184 shares changed hands during trading, a decline of 98% from the average session volume of 1,692,515 shares. The stock had […] - 2025-03-14 04:23:07
Caprock Group LLC Sells 2,500 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT): Caprock Group LLC lessened its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 19.4% during the 4th quarter, Holdings Channel reports. The firm owned 10,415 shares of the company’s stock after selling 2,500 shares during the quarter. Caprock Group LLC’s holdings in Adaptive Biotechnologies were worth $62,000 at the end of the most […] - 2025-02-08 06:49:17
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by China Universal Asset Management Co. Ltd.: China Universal Asset Management Co. Ltd. increased its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 10.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 31,292 shares of the company’s stock after buying an additional 2,928 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Adaptive Biotechnologies […] - 2025-02-04 06:53:02

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ADPT holdings

Date	Number of ADPT Shares Held	Base Market Value of ADPT Shares	Local Market Value of ADPT Shares	Change in ADPT Shares Held	Change in ADPT Base Value	Current Price per ADPT Share Held	Previous Price per ADPT Share Held
2025-12-03 (Wednesday)	105,785	USD 1,812,097	USD 1,812,097	0	USD -165,025	USD 17.13	USD 18.69
2025-12-02 (Tuesday)	105,785	USD 1,977,122	USD 1,977,122	3,780	USD 55,348	USD 18.69	USD 18.84
2025-12-01 (Monday)	102,005	USD 1,921,774	USD 1,921,774	0	USD -83,644	USD 18.84	USD 19.66
2025-11-28 (Friday)	102,005	USD 2,005,418	USD 2,005,418	252	USD -1,151	USD 19.66	USD 19.72
2025-11-27 (Thursday)	101,753	USD 2,006,569	USD 2,006,569	0	USD 0	USD 19.72	USD 19.72
2025-11-26 (Wednesday)	101,753	USD 2,006,569	USD 2,006,569	756	USD -45,690	USD 19.72	USD 20.32
2025-11-25 (Tuesday)	100,997	USD 2,052,259	USD 2,052,259	1,260	USD 11,640	USD 20.32	USD 20.46
2025-11-24 (Monday)	99,737	USD 2,040,619	USD 2,040,619	252	USD 189,203	USD 20.46	USD 18.61
2025-11-21 (Friday)	99,485	USD 1,851,416	USD 1,851,416	0	USD 227,821	USD 18.61	USD 16.32
2025-11-20 (Thursday)	99,485	USD 1,623,595	USD 1,623,595	-1,008	USD 101,126	USD 16.32	USD 15.15
2025-11-19 (Wednesday)	100,493	USD 1,522,469	USD 1,522,469	252	USD 144,155	USD 15.15	USD 13.75
2025-11-18 (Tuesday)	100,241	USD 1,378,314	USD 1,378,314	1,512	USD 24,739	USD 13.75	USD 13.71
2025-11-17 (Monday)	98,729	USD 1,353,575	USD 1,353,575	504	USD -31,398	USD 13.71	USD 14.1

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ADPT by Blackrock for IE00BDZVHG35

Show aggregate share trades of ADPT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 3,780 19.270 18.520 18.595 USD 70,290 9.86
2025-11-28 BUY 252 19.720 19.250 19.297 USD 4,863 9.77
2025-11-26 BUY 756 20.340 19.400 19.494 USD 14,737 9.67
2025-11-26 BUY 756 20.340 19.400 19.494 USD 14,737 9.67
2025-11-25 BUY 1,260 20.740 19.610 19.723 USD 24,851 9.62
2025-11-24 BUY 252 20.650 18.400 18.625 USD 4,693 9.56
2025-11-20 SELL -1,008 16.970 15.630 15.764 USD -15,890 9.48 Loss of -6,329 on sale
2025-11-19 BUY 252 15.380 13.725 13.891 USD 3,500 9.46
2025-11-18 BUY 1,512 13.950 13.280 13.347 USD 20,181 9.43
2025-11-17 BUY 504 14.240 13.650 13.709 USD 6,909 9.41
2025-11-14 BUY 252 14.210 13.450 13.526 USD 3,409 9.39
2025-11-12 BUY 252 15.050 14.360 14.429 USD 3,636 9.34
2025-11-10 BUY 250 15.190 14.350 14.434 USD 3,609 9.28
2025-11-06 BUY 250 17.380 15.380 15.580 USD 3,895 9.22
2025-11-04 BUY 251 17.510 16.510 16.610 USD 4,169 9.13
2025-10-30 BUY 1,255 17.365 16.780 16.839 USD 21,132 9.00
2025-10-29 BUY 502 16.800 17.400 17.340 USD 8,705 8.95
2025-10-22 SELL -1,004 16.450 17.240 17.161 USD -17,230 8.73 Loss of -8,469 on sale
2025-10-20 BUY 502 17.830 17.870 17.866 USD 8,969 8.62
2025-10-17 BUY 1,254 16.300 17.200 17.110 USD 21,456 8.58
2025-10-15 BUY 2,000 17.110 17.140 17.137 USD 34,274 8.53
2025-10-03 BUY 1,764 14.380 14.890 14.839 USD 26,176 8.45
2025-10-02 BUY 252 14.240 14.740 14.690 USD 3,702 8.42
2025-09-30 BUY 504 14.960 15.040 15.032 USD 7,576 8.34
2025-09-26 BUY 504 13.220 13.250 13.247 USD 6,676 8.28
2025-09-25 BUY 504 13.130 13.330 13.310 USD 6,708 8.25
2025-09-18 BUY 261 13.770 13.790 13.788 USD 3,599 8.22
2025-09-17 BUY 786 12.820 13.330 13.279 USD 10,437 8.19
2025-09-11 SELL -262 13.490 13.680 13.661 USD -3,579 8.13 Loss of -1,449 on sale
2025-09-10 BUY 524 12.420 13.015 12.956 USD 6,789 8.10
2025-07-17 SELL -522 10.500 10.865 10.828 USD -5,652 8.03 Loss of -1,462 on sale
2025-07-11 SELL -2,088 11.820 12.050 12.027 USD -25,112 7.94 Loss of -8,530 on sale
2025-07-02 BUY 14,355 11.480 11.805 11.773 USD 168,994 7.84
2025-06-25 BUY 522 11.980 12.070 12.061 USD 6,296 7.72
2025-06-20 BUY 5,336 10.380 10.700 10.668 USD 56,924 7.66
2025-06-11 BUY 488 10.630 10.870 10.846 USD 5,293 7.52
2025-06-10 BUY 488 10.460 10.709 10.684 USD 5,214 7.50
2025-06-04 SELL -244 9.980 10.250 10.223 USD -2,494 7.42 Loss of -685 on sale
2025-04-23 BUY 245 7.380 7.860 7.812 USD 1,914 6.97
2025-04-10 SELL -1,952 7.725 8.140 8.099 USD -15,808 6.92 Loss of -2,295 on sale
2025-04-08 SELL -244 7.665 8.490 8.407 USD -2,051 6.90 Loss of -368 on sale
2025-04-07 SELL -244 7.705 8.140 8.097 USD -1,976 6.89 Loss of -295 on sale
2025-04-04 SELL -1,225 7.470 7.620 7.605 USD -9,316 6.88 Loss of -887 on sale
2025-04-01 BUY 1,012 7.520 7.630 7.619 USD 7,710 6.86
2025-03-31 SELL -738 7.430 7.680 7.655 USD -5,649 6.85 Loss of -591 on sale
2025-03-21 BUY 3,315 8.400 8.660 8.634 USD 28,622 6.74
2025-03-14 SELL -3,792 7.280 7.450 7.433 USD -28,186 6.69 Loss of -2,822 on sale
2025-03-07 SELL -470 7.350 7.920 7.863 USD -3,696 6.65 Loss of -572 on sale
2025-03-04 SELL -235 8.120 8.300 8.282 USD -1,946 6.58 Loss of -399 on sale
2025-02-25 BUY 470 8.420 8.518 8.508 USD 3,999 6.44
2025-02-19 SELL -234 8.370 8.665 8.635 USD -2,021 6.30 Loss of -547 on sale
2025-02-13 BUY 702 8.520 8.560 8.556 USD 6,006 6.13
2025-02-12 BUY 234 7.550 7.710 7.694 USD 1,800 6.10
2025-02-11 BUY 936 7.800 7.920 7.908 USD 7,402 6.07
2024-12-30 SELL -11,651 6.110 6.230 6.218 USD -72,446 5.37 Loss of -9,862 on sale
2024-11-18 SELL -4,020 4.680 5.100 5.058 USD -20,333 5.09 Profit of 144 on sale
2024-11-08 SELL -268 5.820 6.330 6.279 USD -1,683 4.98 Loss of -348 on sale
2024-10-21 SELL -272 4.550 4.620 4.613 USD -1,255 0.00 Loss of -1,255 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	3,780	19.270	18.520	18.595	USD 70,290	9.86
2025-11-28	BUY	252	19.720	19.250	19.297	USD 4,863	9.77
2025-11-26	BUY	756	20.340	19.400	19.494	USD 14,737	9.67
2025-11-26	BUY	756	20.340	19.400	19.494	USD 14,737	9.67
2025-11-25	BUY	1,260	20.740	19.610	19.723	USD 24,851	9.62
2025-11-24	BUY	252	20.650	18.400	18.625	USD 4,693	9.56
2025-11-20	SELL	-1,008	16.970	15.630	15.764	USD -15,890	9.48 Loss of -6,329 on sale
2025-11-19	BUY	252	15.380	13.725	13.891	USD 3,500	9.46
2025-11-18	BUY	1,512	13.950	13.280	13.347	USD 20,181	9.43
2025-11-17	BUY	504	14.240	13.650	13.709	USD 6,909	9.41
2025-11-14	BUY	252	14.210	13.450	13.526	USD 3,409	9.39
2025-11-12	BUY	252	15.050	14.360	14.429	USD 3,636	9.34
2025-11-10	BUY	250	15.190	14.350	14.434	USD 3,609	9.28
2025-11-06	BUY	250	17.380	15.380	15.580	USD 3,895	9.22
2025-11-04	BUY	251	17.510	16.510	16.610	USD 4,169	9.13
2025-10-30	BUY	1,255	17.365	16.780	16.839	USD 21,132	9.00
2025-10-29	BUY	502	16.800	17.400	17.340	USD 8,705	8.95
2025-10-22	SELL	-1,004	16.450	17.240	17.161	USD -17,230	8.73 Loss of -8,469 on sale
2025-10-20	BUY	502	17.830	17.870	17.866	USD 8,969	8.62
2025-10-17	BUY	1,254	16.300	17.200	17.110	USD 21,456	8.58
2025-10-15	BUY	2,000	17.110	17.140	17.137	USD 34,274	8.53
2025-10-03	BUY	1,764	14.380	14.890	14.839	USD 26,176	8.45
2025-10-02	BUY	252	14.240	14.740	14.690	USD 3,702	8.42
2025-09-30	BUY	504	14.960	15.040	15.032	USD 7,576	8.34
2025-09-26	BUY	504	13.220	13.250	13.247	USD 6,676	8.28
2025-09-25	BUY	504	13.130	13.330	13.310	USD 6,708	8.25
2025-09-18	BUY	261	13.770	13.790	13.788	USD 3,599	8.22
2025-09-17	BUY	786	12.820	13.330	13.279	USD 10,437	8.19
2025-09-11	SELL	-262	13.490	13.680	13.661	USD -3,579	8.13 Loss of -1,449 on sale
2025-09-10	BUY	524	12.420	13.015	12.956	USD 6,789	8.10
2025-07-17	SELL	-522	10.500	10.865	10.828	USD -5,652	8.03 Loss of -1,462 on sale
2025-07-11	SELL	-2,088	11.820	12.050	12.027	USD -25,112	7.94 Loss of -8,530 on sale
2025-07-02	BUY	14,355	11.480	11.805	11.773	USD 168,994	7.84
2025-06-25	BUY	522	11.980	12.070	12.061	USD 6,296	7.72
2025-06-20	BUY	5,336	10.380	10.700	10.668	USD 56,924	7.66
2025-06-11	BUY	488	10.630	10.870	10.846	USD 5,293	7.52
2025-06-10	BUY	488	10.460	10.709	10.684	USD 5,214	7.50
2025-06-04	SELL	-244	9.980	10.250	10.223	USD -2,494	7.42 Loss of -685 on sale
2025-04-23	BUY	245	7.380	7.860	7.812	USD 1,914	6.97
2025-04-10	SELL	-1,952	7.725	8.140	8.099	USD -15,808	6.92 Loss of -2,295 on sale
2025-04-08	SELL	-244	7.665	8.490	8.407	USD -2,051	6.90 Loss of -368 on sale
2025-04-07	SELL	-244	7.705	8.140	8.097	USD -1,976	6.89 Loss of -295 on sale
2025-04-04	SELL	-1,225	7.470	7.620	7.605	USD -9,316	6.88 Loss of -887 on sale
2025-04-01	BUY	1,012	7.520	7.630	7.619	USD 7,710	6.86
2025-03-31	SELL	-738	7.430	7.680	7.655	USD -5,649	6.85 Loss of -591 on sale
2025-03-21	BUY	3,315	8.400	8.660	8.634	USD 28,622	6.74
2025-03-14	SELL	-3,792	7.280	7.450	7.433	USD -28,186	6.69 Loss of -2,822 on sale
2025-03-07	SELL	-470	7.350	7.920	7.863	USD -3,696	6.65 Loss of -572 on sale
2025-03-04	SELL	-235	8.120	8.300	8.282	USD -1,946	6.58 Loss of -399 on sale
2025-02-25	BUY	470	8.420	8.518	8.508	USD 3,999	6.44
2025-02-19	SELL	-234	8.370	8.665	8.635	USD -2,021	6.30 Loss of -547 on sale
2025-02-13	BUY	702	8.520	8.560	8.556	USD 6,006	6.13
2025-02-12	BUY	234	7.550	7.710	7.694	USD 1,800	6.10
2025-02-11	BUY	936	7.800	7.920	7.908	USD 7,402	6.07
2024-12-30	SELL	-11,651	6.110	6.230	6.218	USD -72,446	5.37 Loss of -9,862 on sale
2024-11-18	SELL	-4,020	4.680	5.100	5.058	USD -20,333	5.09 Profit of 144 on sale
2024-11-08	SELL	-268	5.820	6.330	6.279	USD -1,683	4.98 Loss of -348 on sale
2024-10-21	SELL	-272	4.550	4.620	4.613	USD -1,255	0.00 Loss of -1,255 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ADPT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	183,543	565	678,196	27.1%
2025-09-18	219,538	100	525,334	41.8%
2025-09-17	144,306	0	449,136	32.1%
2025-09-16	168,515	1,364	503,732	33.5%
2025-09-15	304,004	190	678,444	44.8%
2025-09-12	236,983	345	749,572	31.6%
2025-09-11	641,057	403	1,408,513	45.5%
2025-09-10	359,776	0	643,550	55.9%
2025-09-09	148,037	39	391,741	37.8%
2025-09-08	135,908	0	632,796	21.5%
2025-09-05	176,315	0	459,137	38.4%
2025-09-04	336,107	19,884	807,447	41.6%
2025-09-03	242,298	0	690,057	35.1%
2025-09-02	140,159	0	394,575	35.5%
2025-08-29	150,552	518	442,626	34.0%
2025-08-28	207,286	2,242	764,039	27.1%
2025-08-27	331,489	2,189	747,448	44.3%
2025-08-26	147,862	0	411,696	35.9%
2025-08-25	126,226	0	408,757	30.9%
2025-08-22	246,436	8,428	672,352	36.7%
2025-08-21	206,643	670	526,704	39.2%
2025-08-20	147,583	112	372,441	39.6%
2025-08-19	344,848	6,507	817,818	42.2%
2025-08-18	376,014	16,013	1,014,967	37.0%
2025-08-15	229,967	300	545,253	42.2%
2025-08-14	236,282	0	491,379	48.1%
2025-08-13	564,782	350	911,126	62.0%
2025-08-12	263,320	5,500	683,935	38.5%
2025-08-11	171,913	10	533,543	32.2%
2025-08-08	477,828	6,869	1,125,299	42.5%
2025-08-07	800,467	2,550	1,840,916	43.5%
2025-08-06	1,284,957	776	2,185,981	58.8%
2025-08-05	705,035	1,269	1,231,430	57.3%
2025-08-04	336,437	100	496,268	67.8%
2025-08-01	292,345	241	437,561	66.8%
2025-07-31	304,488	2,165	561,198	54.3%
2025-07-30	251,383	0	426,516	58.9%
2025-07-29	162,282	222	284,023	57.1%
2025-07-28	161,484	200	312,641	51.7%
2025-07-25	288,635	0	521,204	55.4%
2025-07-24	326,311	2,900	539,821	60.4%
2025-07-23	285,721	417	458,303	62.3%
2025-07-22	382,486	1,372	596,493	64.1%
2025-07-21	391,687	0	570,024	68.7%
2025-07-18	290,418	1,333	454,663	63.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE